StockWatch
·

Alamar Biosciences, Inc.

Ticker: 2104204

P/L Snapshot

Q3 FY26 · consolidated

vs Q2 FY26·vs Q3 FY25
Revenue
33.55
+14.0%+68.5%
Expenditure
48.68
+13.3%+75.1%
Net Profit
-13.34
-1.1%-66.8%
OPM %
-45.13%
+0.85pp-5.53pp

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-29.73-8.0313.6835.3857.08Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
Price Chart
Latest News